UK MHRA Follows EU In Reviewing Pseudoephedrine OTC Medicines
Executive Summary
Following the European medicines regulator, EMA, the UK MHRA has initiated its own review of pseudoephedrine-containing OTC medicines based on the risk of rare side effects, including posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome.